Role of D-type cyclins in heart development and disease

Adam Hotchkiss1, Jessica Robinson, Jessica MacLean

  • 1Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.

Insights

Embryonic heart cells proliferate, but adult heart cells permanently exit the cell cycle. Understanding D-type cyclins in heart development may unlock cardiac regeneration strategies for cardiovascular disease.

Area of Science:

  • Cardiovascular Biology
  • Cell Cycle Regulation
  • Developmental Biology

Background:

  • Embryonic cardiomyocytes exhibit high proliferation rates, which significantly decrease by the perinatal period, leading to limited adult heart regeneration.
  • D-type cyclins (cyclin D1, D2, D3) and cyclin-dependent kinases regulate cardiomyocyte proliferation during normal heart development.
  • Adult hearts show low D-type cyclin expression, though it increases during cardiac hypertrophy, uncoupled from cell division.

Purpose of the Study:

  • To investigate the role of D-type cyclins in regulating cardiomyocyte proliferation during development and in the adult heart.
  • To understand the distinct mechanisms of D-type cyclin regulation in embryonic versus adult cardiomyocytes.
  • To identify potential therapeutic targets for reactivating cardiomyocyte cell cycle in cardiovascular disease.

Main Methods:

  • Analysis of D-type cyclin expression patterns during cardiac development and in adult hearts.
  • Investigation of signaling pathways regulating D-type cyclin production and activity.
  • Comparative analysis of intracellular mediators in embryonic and adult cardiomyocytes.

Main Results:

  • D-type cyclins are crucial for embryonic cardiomyocyte proliferation but are dysregulated in adult cardiac hypertrophy.
  • Reactivation of D-type cyclins in adult hearts is linked to pathological processes, not regeneration.
  • Differential intracellular signaling pathways mediate D-type cyclin function in embryonic versus adult cardiomyocytes.

Conclusions:

  • The distinct roles and regulation of D-type cyclins in embryonic and adult cardiomyocytes highlight developmental differences.
  • Targeting specific intracellular mediators may offer a strategy to promote cardiomyocyte cell cycle re-entry for cardiac repair.
  • Further research into these pathways is essential for developing novel therapies for adult cardiovascular diseases.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...